Global Recombinant Humanized Collagen Market Research Report 2025

Recombinant Humanized Collagen Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Humanized Collagen competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Recombinant humanized collagen refers to the introduction of collagen sequences encoded by human genes into cells for expression and production through gene recombination technology to obtain proteins with the same or similar structural and biological characteristics as natural collagen. Recombinant humanized collagen has many advantages, such as controllable production process, high purity, non-infectiousness, etc. It has a wide range of application prospects in medicine, biotechnology, cosmetics and other fields. Recombinant humanized collagen can be used as a biological material in tissue repair and regenerative medicine, including muscles, bones, soft tissues, etc. In addition, it can also be used as a drug carrier for sustained-release drugs, such as heparin, thiazolidinone, etc., to improve the stability and bioavailability of the drug. At the same time, it can also be used to produce medical devices and medical materials such as artificial skin and artificial cornea. Recombinant humanized collagen can be used in cell culture, gene transfection, vaccine production and other aspects. It can act as a scaffold or matrix in cell culture and gene transfection, improve cell adhesion and proliferation, and promote the development of tissue engineering and stem cell research. In terms of vaccine production, recombinant humanized collagen can be used as a vaccine carrier to improve the immunogenicity and efficacy of the vaccine. Recombinant humanized collagen can be used as an ingredient for efficient anti-wrinkle, moisturizing and skin repair, and is widely used in skin care products, makeup and other products. Recombinant humanized collagen has the same amino acid sequence and tertiary structure as natural collagen, which can act directly on the skin, promote the regeneration and repair of skin cells, and improve the elasticity and gloss of the skin.The Medical Device Standard Management Center of the State Food and Drug Administration issued an interpretation of the "Guiding Principles for the Naming of Recombinant Collagen Biomaterials", which divides recombinant humanized collagen into two types, type A and type B based on whether it contains non-human collagen amino acid sequences. Type A refers to materials that do not contain non-human collagen amino acid sequences, including full-length amino acid sequences encoded by human collagen specific type genes (without triple helical structure), or partial amino acid sequence fragments encoded by human collagen specific type genes, or a combination of human collagen functional fragments (the amino acid sequences do not contain non-human collagen amino acid sequences such as linking amino acids and tag amino acids). Type B refers to the material that adds non-human collagen amino acid sequences such as amino acids and tag amino acids based on the combination of human collagen functional fragments.

Compared with animal-derived collagen, recombinant collagen has a series of obvious advantages, including higher biological activity and biocompatibility, lower immunogenicity, lower risk of missed pathogens, better water solubility, non-cytotoxicity, and can be further processed and optimized. In addition, the denaturing temperature of recombinant collagen exceeds 72°C, which is much higher than 40°C for animal-derived collagen, which makes it more stable during transportation and storage. Therefore, as a safer material, recombinant collagen is more suitable for beauty and health products. With the advancement of the industry and the development of technology, its popularity and market penetration are gradually increasing. According to the "Guiding Principles for the Naming of Recombinant Collagen Biomaterials", recombinant collagen is divided into three main categories: recombinant human collagen, recombinant humanized collagen and recombinant collagen. The core differences in these three types of recombinant collagen are reflected in the construction of expression systems, host selection, protein expression, etc. As the homologous and similarity of gene sequences increases, the expression efficiency and biological activity function of collagen vectors will also be improved accordingly.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Humanized Collagen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Humanized Collagen.

The Recombinant Humanized Collagen market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Humanized Collagen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Humanized Collagen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Humanized Collagen Market Report

Core Chapters

1.1 Product Definition

1.2 Recombinant Humanized Collagen by Type

1.2.1 Global Recombinant Humanized Collagen Market Value Comparison by Type (2024 VS 2031)

1.2.2 Type A

1.2.3 Type B

1.3 Recombinant Humanized Collagen by Application

1.3.1 Global Recombinant Humanized Collagen Market Value by Application (2024 VS 2031)

1.3.2 Medicine

1.3.3 Biotechnology

1.3.4 Cosmetics

1.3.5 Other

1.4 Global Recombinant Humanized Collagen Market Size Estimates and Forecasts

1.4.1 Global Recombinant Humanized Collagen Revenue 2020-2031

1.4.2 Global Recombinant Humanized Collagen Sales 2020-2031

1.4.3 Global Recombinant Humanized Collagen Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2.1 Global Recombinant Humanized Collagen Sales Market Share by Manufacturers (2020-2025)

2.2 Global Recombinant Humanized Collagen Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Recombinant Humanized Collagen Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Recombinant Humanized Collagen, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Humanized Collagen, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Humanized Collagen, Product Type & Application

2.7 Global Key Manufacturers of Recombinant Humanized Collagen, Date of Enter into This Industry

2.8 Global Recombinant Humanized Collagen Market Competitive Situation and Trends

2.8.1 Global Recombinant Humanized Collagen Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Recombinant Humanized Collagen Players Market Share by Revenue

2.8.3 Global Recombinant Humanized Collagen Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Recombinant Humanized Collagen Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Recombinant Humanized Collagen Sales by Region: 2020-2031

3.2.1 Global Recombinant Humanized Collagen Sales by Region: 2020-2025

3.2.2 Global Recombinant Humanized Collagen Sales by Region: 2026-2031

3.3 Global Recombinant Humanized Collagen Revenue by Region: 2020-2031

3.3.1 Global Recombinant Humanized Collagen Revenue by Region: 2020-2025

3.3.2 Global Recombinant Humanized Collagen Revenue by Region: 2026-2031

3.4 North America Recombinant Humanized Collagen Market Facts & Figures by Country

3.4.1 North America Recombinant Humanized Collagen Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Recombinant Humanized Collagen Sales by Country (2020-2031)

3.4.3 North America Recombinant Humanized Collagen Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Recombinant Humanized Collagen Market Facts & Figures by Country

3.5.1 Europe Recombinant Humanized Collagen Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Recombinant Humanized Collagen Sales by Country (2020-2031)

3.5.3 Europe Recombinant Humanized Collagen Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Humanized Collagen Market Facts & Figures by Region

3.6.1 Asia Pacific Recombinant Humanized Collagen Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Recombinant Humanized Collagen Sales by Region (2020-2031)

3.6.3 Asia Pacific Recombinant Humanized Collagen Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Recombinant Humanized Collagen Market Facts & Figures by Country

3.7.1 Latin America Recombinant Humanized Collagen Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Recombinant Humanized Collagen Sales by Country (2020-2031)

3.7.3 Latin America Recombinant Humanized Collagen Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Humanized Collagen Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Humanized Collagen Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Recombinant Humanized Collagen Sales by Country (2020-2031)

3.8.3 Middle East and Africa Recombinant Humanized Collagen Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Recombinant Humanized Collagen Sales by Type (2020-2031)

4.1.1 Global Recombinant Humanized Collagen Sales by Type (2020-2025)

4.1.2 Global Recombinant Humanized Collagen Sales by Type (2026-2031)

4.1.3 Global Recombinant Humanized Collagen Sales Market Share by Type (2020-2031)

4.2 Global Recombinant Humanized Collagen Revenue by Type (2020-2031)

4.2.1 Global Recombinant Humanized Collagen Revenue by Type (2020-2025)

4.2.2 Global Recombinant Humanized Collagen Revenue by Type (2026-2031)

4.2.3 Global Recombinant Humanized Collagen Revenue Market Share by Type (2020-2031)

4.3 Global Recombinant Humanized Collagen Price by Type (2020-2031)

5.1 Global Recombinant Humanized Collagen Sales by Application (2020-2031)

5.1.1 Global Recombinant Humanized Collagen Sales by Application (2020-2025)

5.1.2 Global Recombinant Humanized Collagen Sales by Application (2026-2031)

5.1.3 Global Recombinant Humanized Collagen Sales Market Share by Application (2020-2031)

5.2 Global Recombinant Humanized Collagen Revenue by Application (2020-2031)

5.2.1 Global Recombinant Humanized Collagen Revenue by Application (2020-2025)

5.2.2 Global Recombinant Humanized Collagen Revenue by Application (2026-2031)

5.2.3 Global Recombinant Humanized Collagen Revenue Market Share by Application (2020-2031)

5.3 Global Recombinant Humanized Collagen Price by Application (2020-2031)

6.1 Giant Biogene

6.1.1 Giant Biogene Company Information

6.1.2 Giant Biogene Description and Business Overview

6.1.3 Giant Biogene Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Giant Biogene Recombinant Humanized Collagen Product Portfolio

6.1.5 Giant Biogene Recent Developments/Updates

6.2 Shanxi Jinbo Bio-Pharmaceutical

6.2.1 Shanxi Jinbo Bio-Pharmaceutical Company Information

6.2.2 Shanxi Jinbo Bio-Pharmaceutical Description and Business Overview

6.2.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Portfolio

6.2.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates

6.3 Jiangsu JLand Biotech

6.3.1 Jiangsu JLand Biotech Company Information

6.3.2 Jiangsu JLand Biotech Description and Business Overview

6.3.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Jiangsu JLand Biotech Recombinant Humanized Collagen Product Portfolio

6.3.5 Jiangsu JLand Biotech Recent Developments/Updates

6.4 Jiangsu Chuangjian Medical Technology

6.4.1 Jiangsu Chuangjian Medical Technology Company Information

6.4.2 Jiangsu Chuangjian Medical Technology Description and Business Overview

6.4.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Portfolio

6.4.5 Jiangsu Chuangjian Medical Technology Recent Developments/Updates

6.5 Evonik

6.5.1 Evonik Company Information

6.5.2 Evonik Description and Business Overview

6.5.3 Evonik Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Evonik Recombinant Humanized Collagen Product Portfolio

6.5.5 Evonik Recent Developments/Updates

6.6 ProColl

6.6.1 ProColl Company Information

6.6.2 ProColl Description and Business Overview

6.6.3 ProColl Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.6.4 ProColl Recombinant Humanized Collagen Product Portfolio

6.6.5 ProColl Recent Developments/Updates

6.7 CollPlant

6.7.1 CollPlant Company Information

6.7.2 CollPlant Description and Business Overview

6.7.3 CollPlant Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.7.4 CollPlant Recombinant Humanized Collagen Product Portfolio

6.7.5 CollPlant Recent Developments/Updates

6.8 Creative BioMart

6.8.1 Creative BioMart Company Information

6.8.2 Creative BioMart Description and Business Overview

6.8.3 Creative BioMart Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Creative BioMart Recombinant Humanized Collagen Product Portfolio

6.8.5 Creative BioMart Recent Developments/Updates

7.1 Recombinant Humanized Collagen Industry Chain Analysis

7.2 Recombinant Humanized Collagen Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Humanized Collagen Production Mode & Process Analysis

7.4 Recombinant Humanized Collagen Sales and Marketing

7.4.1 Recombinant Humanized Collagen Sales Channels

7.4.2 Recombinant Humanized Collagen Distributors

7.5 Recombinant Humanized Collagen Customer Analysis

8.1 Recombinant Humanized Collagen Industry Trends

8.2 Recombinant Humanized Collagen Market Drivers

8.3 Recombinant Humanized Collagen Market Challenges

8.4 Recombinant Humanized Collagen Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Recombinant Humanized Collagen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

 Table 2. Global Recombinant Humanized Collagen Market Value by Application (2024 VS 2031) & (US$ Million)

 Table 3. Global Recombinant Humanized Collagen Market Competitive Situation by Manufacturers in 2024

 Table 4. Global Recombinant Humanized Collagen Sales (Tons) of Key Manufacturers (2020-2025)

 Table 5. Global Recombinant Humanized Collagen Sales Market Share by Manufacturers (2020-2025)

 Table 6. Global Recombinant Humanized Collagen Revenue (US$ Million) by Manufacturers (2020-2025)

 Table 7. Global Recombinant Humanized Collagen Revenue Share by Manufacturers (2020-2025)

 Table 8. Global Market Recombinant Humanized Collagen Average Price (US$/kg) of Key Manufacturers (2020-2025)

 Table 9. Global Key Players of Recombinant Humanized Collagen, Industry Ranking, 2022 VS 2023 VS 2024

 Table 10. Global Key Manufacturers of Recombinant Humanized Collagen, Manufacturing Sites & Headquarters

 Table 11. Global Key Manufacturers of Recombinant Humanized Collagen, Product Type & Application

 Table 12. Global Key Manufacturers of Recombinant Humanized Collagen, Date of Enter into This Industry

 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 14. Global Recombinant Humanized Collagen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Humanized Collagen as of 2024)

 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 16. Global Recombinant Humanized Collagen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 17. Global Recombinant Humanized Collagen Sales by Region (2020-2025) & (Tons)

 Table 18. Global Recombinant Humanized Collagen Sales Market Share by Region (2020-2025)

 Table 19. Global Recombinant Humanized Collagen Sales by Region (2026-2031) & (Tons)

 Table 20. Global Recombinant Humanized Collagen Sales Market Share by Region (2026-2031)

 Table 21. Global Recombinant Humanized Collagen Revenue by Region (2020-2025) & (US$ Million)

 Table 22. Global Recombinant Humanized Collagen Revenue Market Share by Region (2020-2025)

 Table 23. Global Recombinant Humanized Collagen Revenue by Region (2026-2031) & (US$ Million)

 Table 24. Global Recombinant Humanized Collagen Revenue Market Share by Region (2026-2031)

 Table 25. North America Recombinant Humanized Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 26. North America Recombinant Humanized Collagen Sales by Country (2020-2025) & (Tons)

 Table 27. North America Recombinant Humanized Collagen Sales by Country (2026-2031) & (Tons)

 Table 28. North America Recombinant Humanized Collagen Revenue by Country (2020-2025) & (US$ Million)

 Table 29. North America Recombinant Humanized Collagen Revenue by Country (2026-2031) & (US$ Million)

 Table 30. Europe Recombinant Humanized Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 31. Europe Recombinant Humanized Collagen Sales by Country (2020-2025) & (Tons)

 Table 32. Europe Recombinant Humanized Collagen Sales by Country (2026-2031) & (Tons)

 Table 33. Europe Recombinant Humanized Collagen Revenue by Country (2020-2025) & (US$ Million)

 Table 34. Europe Recombinant Humanized Collagen Revenue by Country (2026-2031) & (US$ Million)

 Table 35. Asia Pacific Recombinant Humanized Collagen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

 Table 36. Asia Pacific Recombinant Humanized Collagen Sales by Region (2020-2025) & (Tons)

 Table 37. Asia Pacific Recombinant Humanized Collagen Sales by Region (2026-2031) & (Tons)

 Table 38. Asia Pacific Recombinant Humanized Collagen Revenue by Region (2020-2025) & (US$ Million)

 Table 39. Asia Pacific Recombinant Humanized Collagen Revenue by Region (2026-2031) & (US$ Million)

 Table 40. Latin America Recombinant Humanized Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 41. Latin America Recombinant Humanized Collagen Sales by Country (2020-2025) & (Tons)

 Table 42. Latin America Recombinant Humanized Collagen Sales by Country (2026-2031) & (Tons)

 Table 43. Latin America Recombinant Humanized Collagen Revenue by Country (2020-2025) & (US$ Million)

 Table 44. Latin America Recombinant Humanized Collagen Revenue by Country (2026-2031) & (US$ Million)

 Table 45. Middle East and Africa Recombinant Humanized Collagen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

 Table 46. Middle East and Africa Recombinant Humanized Collagen Sales by Country (2020-2025) & (Tons)

 Table 47. Middle East and Africa Recombinant Humanized Collagen Sales by Country (2026-2031) & (Tons)

 Table 48. Middle East and Africa Recombinant Humanized Collagen Revenue by Country (2020-2025) & (US$ Million)

 Table 49. Middle East and Africa Recombinant Humanized Collagen Revenue by Country (2026-2031) & (US$ Million)

 Table 50. Global Recombinant Humanized Collagen Sales (Tons) by Type (2020-2025)

 Table 51. Global Recombinant Humanized Collagen Sales (Tons) by Type (2026-2031)

 Table 52. Global Recombinant Humanized Collagen Sales Market Share by Type (2020-2025)

 Table 53. Global Recombinant Humanized Collagen Sales Market Share by Type (2026-2031)

 Table 54. Global Recombinant Humanized Collagen Revenue (US$ Million) by Type (2020-2025)

 Table 55. Global Recombinant Humanized Collagen Revenue (US$ Million) by Type (2026-2031)

 Table 56. Global Recombinant Humanized Collagen Revenue Market Share by Type (2020-2025)

 Table 57. Global Recombinant Humanized Collagen Revenue Market Share by Type (2026-2031)

 Table 58. Global Recombinant Humanized Collagen Price (US$/kg) by Type (2020-2025)

 Table 59. Global Recombinant Humanized Collagen Price (US$/kg) by Type (2026-2031)

 Table 60. Global Recombinant Humanized Collagen Sales (Tons) by Application (2020-2025)

 Table 61. Global Recombinant Humanized Collagen Sales (Tons) by Application (2026-2031)

 Table 62. Global Recombinant Humanized Collagen Sales Market Share by Application (2020-2025)

 Table 63. Global Recombinant Humanized Collagen Sales Market Share by Application (2026-2031)

 Table 64. Global Recombinant Humanized Collagen Revenue (US$ Million) by Application (2020-2025)

 Table 65. Global Recombinant Humanized Collagen Revenue (US$ Million) by Application (2026-2031)

 Table 66. Global Recombinant Humanized Collagen Revenue Market Share by Application (2020-2025)

 Table 67. Global Recombinant Humanized Collagen Revenue Market Share by Application (2026-2031)

 Table 68. Global Recombinant Humanized Collagen Price (US$/kg) by Application (2020-2025)

 Table 69. Global Recombinant Humanized Collagen Price (US$/kg) by Application (2026-2031)

 Table 70. Giant Biogene Company Information

 Table 71. Giant Biogene Description and Business Overview

 Table 72. Giant Biogene Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 73. Giant Biogene Recombinant Humanized Collagen Product

 Table 74. Giant Biogene Recent Developments/Updates

 Table 75. Shanxi Jinbo Bio-Pharmaceutical Company Information

 Table 76. Shanxi Jinbo Bio-Pharmaceutical Description and Business Overview

 Table 77. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 78. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product

 Table 79. Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates

 Table 80. Jiangsu JLand Biotech Company Information

 Table 81. Jiangsu JLand Biotech Description and Business Overview

 Table 82. Jiangsu JLand Biotech Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 83. Jiangsu JLand Biotech Recombinant Humanized Collagen Product

 Table 84. Jiangsu JLand Biotech Recent Developments/Updates

 Table 85. Jiangsu Chuangjian Medical Technology Company Information

 Table 86. Jiangsu Chuangjian Medical Technology Description and Business Overview

 Table 87. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 88. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product

 Table 89. Jiangsu Chuangjian Medical Technology Recent Developments/Updates

 Table 90. Evonik Company Information

 Table 91. Evonik Description and Business Overview

 Table 92. Evonik Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 93. Evonik Recombinant Humanized Collagen Product

 Table 94. Evonik Recent Developments/Updates

 Table 95. ProColl Company Information

 Table 96. ProColl Description and Business Overview

 Table 97. ProColl Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 98. ProColl Recombinant Humanized Collagen Product

 Table 99. ProColl Recent Developments/Updates

 Table 100. CollPlant Company Information

 Table 101. CollPlant Description and Business Overview

 Table 102. CollPlant Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 103. CollPlant Recombinant Humanized Collagen Product

 Table 104. CollPlant Recent Developments/Updates

 Table 105. Creative BioMart Company Information

 Table 106. Creative BioMart Description and Business Overview

 Table 107. Creative BioMart Recombinant Humanized Collagen Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

 Table 108. Creative BioMart Recombinant Humanized Collagen Product

 Table 109. Creative BioMart Recent Developments/Updates

 Table 110. Key Raw Materials Lists

 Table 111. Raw Materials Key Suppliers Lists

 Table 112. Recombinant Humanized Collagen Distributors List

 Table 113. Recombinant Humanized Collagen Customers List

 Table 114. Recombinant Humanized Collagen Market Trends

 Table 115. Recombinant Humanized Collagen Market Drivers

 Table 116. Recombinant Humanized Collagen Market Challenges

 Table 117. Recombinant Humanized Collagen Market Restraints

 Table 118. Research Programs/Design for This Report

 Table 119. Key Data Information from Secondary Sources

 Table 120. Key Data Information from Primary Sources

 Table 121. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Recombinant Humanized Collagen

 Figure 2. Global Recombinant Humanized Collagen Market Value Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Recombinant Humanized Collagen Market Share by Type: 2024 & 2031

 Figure 4. Type A Product Picture

 Figure 5. Type B Product Picture

 Figure 6. Global Recombinant Humanized Collagen Market Value by Application (2020-2031) & (US$ Million)

 Figure 7. Global Recombinant Humanized Collagen Market Share by Application: 2024 & 2031

 Figure 8. Medicine

 Figure 9. Biotechnology

 Figure 10. Cosmetics

 Figure 11. Other

 Figure 12. Global Recombinant Humanized Collagen Revenue, (US$ Million), 2020 VS 2024 VS 2031

 Figure 13. Global Recombinant Humanized Collagen Market Size (2020-2031) & (US$ Million)

 Figure 14. Global Recombinant Humanized Collagen Sales (2020-2031) & (Tons)

 Figure 15. Global Recombinant Humanized Collagen Average Price (US$/kg) & (2020-2031)

 Figure 16. Recombinant Humanized Collagen Report Years Considered

 Figure 17. Recombinant Humanized Collagen Sales Share by Manufacturers in 2024

 Figure 18. Global Recombinant Humanized Collagen Revenue Share by Manufacturers in 2024

 Figure 19. Global 5 and 10 Largest Recombinant Humanized Collagen Players: Market Share by Revenue in Recombinant Humanized Collagen in 2024

 Figure 20. Recombinant Humanized Collagen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

 Figure 21. Global Recombinant Humanized Collagen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Figure 22. North America Recombinant Humanized Collagen Sales Market Share by Country (2020-2031)

 Figure 23. North America Recombinant Humanized Collagen Revenue Market Share by Country (2020-2031)

 Figure 24. United States Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 25. Canada Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 26. Europe Recombinant Humanized Collagen Sales Market Share by Country (2020-2031)

 Figure 27. Europe Recombinant Humanized Collagen Revenue Market Share by Country (2020-2031)

 Figure 28. Germany Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 29. France Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 30. U.K. Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 31. Italy Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 32. Russia Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 33. Asia Pacific Recombinant Humanized Collagen Sales Market Share by Region (2020-2031)

 Figure 34. Asia Pacific Recombinant Humanized Collagen Revenue Market Share by Region (2020-2031)

 Figure 35. China Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 36. Japan Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 37. South Korea Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 38. India Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 39. Australia Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 40. China Taiwan Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 41. Indonesia Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 42. Thailand Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 43. Malaysia Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 44. Latin America Recombinant Humanized Collagen Sales Market Share by Country (2020-2031)

 Figure 45. Latin America Recombinant Humanized Collagen Revenue Market Share by Country (2020-2031)

 Figure 46. Mexico Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 47. Brazil Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 48. Argentina Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 49. Middle East and Africa Recombinant Humanized Collagen Sales Market Share by Country (2020-2031)

 Figure 50. Middle East and Africa Recombinant Humanized Collagen Revenue Market Share by Country (2020-2031)

 Figure 51. Turkey Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 52. Saudi Arabia Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 53. UAE Recombinant Humanized Collagen Revenue Growth Rate (2020-2031) & (US$ Million)

 Figure 54. Global Sales Market Share of Recombinant Humanized Collagen by Type (2020-2031)

 Figure 55. Global Revenue Market Share of Recombinant Humanized Collagen by Type (2020-2031)

 Figure 56. Global Recombinant Humanized Collagen Price (US$/kg) by Type (2020-2031)

 Figure 57. Global Sales Market Share of Recombinant Humanized Collagen by Application (2020-2031)

 Figure 58. Global Revenue Market Share of Recombinant Humanized Collagen by Application (2020-2031)

 Figure 59. Global Recombinant Humanized Collagen Price (US$/kg) by Application (2020-2031)

 Figure 60. Recombinant Humanized Collagen Value Chain

 Figure 61. Channels of Distribution (Direct Vs Distribution)

 Figure 62. Bottom-up and Top-down Approaches for This Report

 Figure 63. Data Triangulation

 Figure 64. Key Executives Interviewed